Clinical Trials List
Protocol Number1366-0021
Completed
2022-03-01 - 2024-12-02
Phase II
Recruiting1
ICD-10K76.6
Portal hypertension
ICD-9572.3
Portal hypertension
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳佩珊 Division of General Internal Medicine
- Yun-Cheng Hsieh Digestive System Department
- 林漢傑 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
78 participants
